State Street’s Korsana Biosciences KRSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-824
Closed -$50.1K – 4688
2023
Q1
$50.1K Hold
824
– – ﹤0.01% 4502
2022
Q4
$75.7K Hold
824
– – ﹤0.01% 4448
2022
Q3
$99K Hold
824
– – ﹤0.01% 4467
2022
Q2
$63K Sell
824
-1
-0.1% -$100 ﹤0.01% 4673
2022
Q1
$128K Buy
825
+33
+4% +$5.56K ﹤0.01% 4558
2021
Q4
$191K Buy
792
+151
+24% +$49.9K ﹤0.01% 4373
2021
Q3
$275K Buy
641
+46
+8% +$21.1K ﹤0.01% 4233
2021
Q2
$325K Sell
595
-2,263
-79% -$992K ﹤0.01% 4022
2021
Q1
$1.12M Sell
2,858
-194
-6% -$102K ﹤0.01% 3599
2020
Q4
$1.31M Sell
3,052
-84
-3% -$40.1K ﹤0.01% 3508
2020
Q3
$2.67M Sell
3,136
-436
-12% -$349K ﹤0.01% 3084
2020
Q2
$2.96M Sell
3,572
-266
-7% -$156K ﹤0.01% 3020
2020
Q1
$1.42M Buy
3,838
+76
+2% +$38K ﹤0.01% 3199
2019
Q4
$1.43M Buy
3,762
+526
+16% +$344K ﹤0.01% 3341
2019
Q3
$5.49M Buy
3,236
+185
+6% +$280K ﹤0.01% 2739
2019
Q2
$4.89M Buy
+3,051
New +$6.04M ﹤0.01% 2832

Other funds holding KRSA

State Street's KRSA Position: Q2 2023 in Review

State Street sold out of Korsana Biosciences (KRSA) in Q2 2023, closing a stake of 824 shares — an estimated $50.1K sold.

State Street first reported a position in KRSA in Q2 2019 and held it in 16 quarters. The position peaked at $5.49M in Q3 2019. 17 funds tracked by Wall St. Rank hold KRSA as of Q2 2023.

  • State Street reported no remaining Korsana Biosciences position as of Q2 2023 after selling out during the quarter.
  • State Street sold 824 Korsana Biosciences shares in Q2 2023, an estimated $50.1K.
  • State Street first reported a position in Korsana Biosciences in Q2 2019 and held it in 16 quarters.
  • State Street's Korsana Biosciences position peaked at $5.49M in Q3 2019.
  • 17 funds tracked by Wall St. Rank held Korsana Biosciences as of Q2 2023.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.